1CM Inc. (EPIC.CN)
CAD 0.33
(60.98%)
CAD 0.33
(60.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.31 Million CAD | 110.95% |
| 2022 | -3.31 Million CAD | 12.98% |
| 2021 | -3.56 Million CAD | -84.19% |
| 2020 | -2.09 Million CAD | 31.81% |
| 2019 | -28.25 Million CAD | 52.0% |
| 2018 | -6.29 Million CAD | -10767.86% |
| 2017 | -58.98 Thousand CAD | -13.44% |
| 2016 | -51.99 Thousand CAD | -106.24% |
| 2015 | -321.33 Thousand CAD | -29.81% |
| 2014 | 1.18 Million CAD | 7056.38% |
| 2013 | -17.07 Thousand CAD | 93.73% |
| 2012 | -272.22 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 427.68 Thousand CAD | -2.32% |
| 2024 Q1 | 37.13 Thousand CAD | -96.12% |
| 2024 Q2 | 437.81 Thousand CAD | 1079.11% |
| 2023 Q2 | -133.29 Thousand CAD | 66.22% |
| 2023 FY | - CAD | 110.95% |
| 2023 Q1 | -394.61 Thousand CAD | 79.04% |
| 2023 Q4 | 823.72 Thousand CAD | 1038.49% |
| 2023 Q3 | 72.35 Thousand CAD | 154.28% |
| 2022 Q1 | -445.27 Thousand CAD | 81.1% |
| 2022 Q4 | -1.88 Million CAD | -272.52% |
| 2022 Q3 | -505.38 Thousand CAD | 4.53% |
| 2022 FY | - CAD | 12.98% |
| 2022 Q2 | -529.36 Thousand CAD | -18.88% |
| 2021 Q2 | -521.41 Thousand CAD | -5.16% |
| 2021 Q4 | -2.35 Million CAD | -379.37% |
| 2021 FY | - CAD | -84.19% |
| 2021 Q1 | -495.82 Thousand CAD | -3.02% |
| 2021 Q3 | -491.42 Thousand CAD | 5.75% |
| 2020 Q2 | -512.16 Thousand CAD | 14.84% |
| 2020 Q3 | -503.15 Thousand CAD | 1.76% |
| 2020 Q4 | -481.31 Thousand CAD | 4.34% |
| 2020 FY | - CAD | 31.81% |
| 2020 Q1 | -601.4 Thousand CAD | 55.96% |
| 2019 FY | - CAD | 52.0% |
| 2019 Q1 | -933.46 Thousand CAD | 77.24% |
| 2019 Q2 | -915.09 Thousand CAD | 1.97% |
| 2019 Q3 | 199.54 Thousand CAD | 121.81% |
| 2019 Q4 | -1.36 Million CAD | -784.35% |
| 2018 Q4 | -4.1 Million CAD | -101.39% |
| 2018 Q1 | -26.95 Thousand CAD | -82.18% |
| 2018 Q3 | -2.03 Million CAD | -1483.78% |
| 2018 FY | - CAD | -10767.86% |
| 2018 Q2 | -128.56 Thousand CAD | -376.97% |
| 2017 Q2 | -13.09 Thousand CAD | 35.91% |
| 2017 FY | - CAD | -13.44% |
| 2017 Q4 | -14.79 Thousand CAD | -38.93% |
| 2017 Q3 | -10.65 Thousand CAD | 18.7% |
| 2017 Q1 | -20.43 Thousand CAD | -19.49% |
| 2016 Q1 | -3753.00 CAD | -100.66% |
| 2016 FY | - CAD | -106.24% |
| 2016 Q3 | -9236.00 CAD | 57.83% |
| 2016 Q2 | -21.9 Thousand CAD | -483.59% |
| 2016 Q4 | -17.1 Thousand CAD | -85.2% |
| 2015 Q3 | 471.14 Thousand CAD | 555.37% |
| 2015 Q2 | -103.46 Thousand CAD | -4.26% |
| 2015 FY | - CAD | -29.81% |
| 2015 Q1 | -99.23 Thousand CAD | 68.51% |
| 2015 Q4 | 565.06 Thousand CAD | 19.94% |
| 2014 Q2 | 1.63 Million CAD | 2993.07% |
| 2014 Q3 | -76.58 Thousand CAD | -104.68% |
| 2014 Q4 | -315.09 Thousand CAD | -311.42% |
| 2014 FY | - CAD | 7056.38% |
| 2014 Q1 | -56.54 Thousand CAD | 86.71% |
| 2013 Q3 | -25.35 Thousand CAD | 56.36% |
| 2013 Q1 | -157.37 Thousand CAD | -694.97% |
| 2013 FY | - CAD | 93.73% |
| 2013 Q2 | -58.09 Thousand CAD | 63.09% |
| 2013 Q4 | -425.58 Thousand CAD | -1578.69% |
| 2012 Q1 | -3650.00 CAD | 0.0% |
| 2012 Q3 | -45.74 Thousand CAD | 0.0% |
| 2012 Q4 | -19.79 Thousand CAD | 56.73% |
| 2012 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 121.626% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | 165.334% |
| Blueberries Medical Corp. | -1.22 Million CAD | 207.508% |
| The BC Bud Corporation | -1.19 Million CAD | 209.825% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 120.256% |
| CordovaCann Corp. | -1.6 Million CAD | 181.961% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 150.069% |
| Captor Capital Corp. | 2.42 Million CAD | 45.748% |
| City View Green Holdings Inc. | -2.01 Million CAD | 165.205% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | 5397.971% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 159.479% |
| IM Cannabis Corp. | -2.79 Million CAD | 147.08% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 129.837% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | 434.899% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 141.138% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | -15.06% |
| Ovation Science Inc. | -778.83 Thousand CAD | 268.653% |
| Pharmadrug Inc. | -1.33 Million CAD | 198.391% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 121.689% |
| RAMM Pharma Corp. | -6.3 Million CAD | 120.843% |
| RIV Capital Inc. | -20.28 Million CAD | 106.477% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 123.477% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 101.693% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 144.515% |
| 1933 Industries Inc. | -10.03 Million CAD | 113.092% |
| Red Light Holland Corp. | -5.25 Million CAD | 124.992% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | 271.034% |
| Xebra Brands Ltd. | -1.49 Million CAD | 187.862% |
| Adastra Holdings Ltd. | -1.41 Million CAD | 193.074% |